Company intelligence / Profile preview

LIFT Healthcare

London, England, United Kingdomlifthealthcare.com ↗

Ownership: Private
Development stage: Commercial

Overview

LIfT BioSciences has developed a first-in-class allogeneic neutrophil-based cell therapy platform, with preclinical data showing that their Immunomodulatory Alpha Neutrophils can directly kill cancer cells and modulate the immune system to overcome resistance in solid tumors. They are preparing for clinical trials and have secured multiple patents protecting their technology

Therapeutic areas: OncologyInfectious Diseases
Modalities: Cell therapyInduced pluripotent stem cell derived therapyHematopoietic stem cell derived therapyAllogeneic cell therapy
Industry: Biotech

Partnerships

University of Galway – partnership for clinical trial in IrelandBayer Co.Lab Cambridge – access to lab facilities

Beyond the preview

Go deeper on LIFT Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIFT Healthcare.

Explore the full profile